Back
Apellis Pharmaceuticals Stock Predictions
Sponsored
APLS
Sponsored
Election Shock on August 19th?
Click here now to see the evidence I've gathered.
Sell
30
APLS
Apellis Pharmaceuticals
Last Price:
44.18
Seasonality Move:
-1.82%
7 Day Trial
ALL ACCESS PASS
$
7
Unlock the Secret to Earning Monthly Income!
Limited spots act swiftlyApellis Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 23.2% based on the past 6 years of stock performance.
- Apellis Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Apellis Pharmaceuticals Stock Undervalued?
The current Apellis Pharmaceuticals [APLS] share price is $47.84. The Score for APLS is 30, which is 40% below its historic median score of 50, and infers higher risk than normal. - APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Apellis Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 23.2% based on the past 6 years of stock performance.
Apellis Pharmaceuticals Stock Rating
Sell
30
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals overpriced?
- Apellis Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Apellis Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
apellis.com
52-Week Data
52-Week High:
94.75
52-Week Low:
19.83
Prediction Charts
Market Cap:
5.77B
Price in USD:
47.84
Volume:
1.17M
Beta:
0.83
Technical Analysis
SMA50:
57.62
SMA100:
60.55
SMA200:
51.26
52-Wk Change:
-42.66%
Stock Predictions
-
Is Apellis Pharmaceuticals stock public?
Yes, Apellis Pharmaceuticals is a publicly traded company. -
What is the Apellis Pharmaceuticals stock quote today?
The Apellis Pharmaceuticals stock price is 47.84 USD today. -
How to buy Apellis Pharmaceuticals stock online?
You can buy Apellis Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-10 | 53.71 | 56.88 | 57.03 | 53.71 |
Apr-11 | 57.15 | 55.73 | 57.85 | 55.22 |
Apr-12 | 55.13 | 51.78 | 55.60 | 50.07 |
Apr-15 | 51.76 | 51.50 | 53.04 | 50.28 |
Apr-16 | 51.40 | 51.88 | 53.06 | 50.70 |
Apr-17 | 51.67 | 47.98 | 52.44 | 47.96 |
Apr-18 | 47.91 | 47.51 | 48.83 | 46.40 |
Apr-19 | 47.52 | 47.54 | 48.19 | 46.53 |
Apr-22 | 48.08 | 47.64 | 48.42 | 46.63 |
Apr-23 | 48.18 | 48.72 | 50.00 | 47.97 |
Apr-24 | 48.84 | 49.93 | 50.41 | 48.62 |
Apr-25 | 49.27 | 47.93 | 49.31 | 47.02 |
Apr-26 | 50.00 | 49.86 | 50.98 | 48.85 |
Apr-29 | 48.98 | 47.84 | 49.38 | 47.56 |
Apellis Pharmaceuticals Earnings
Apellis Pharmaceuticals Earnings Report: Per Share Apellis Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Apellis Pharmaceuticals Forecast Revenue Growth
Apellis Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Apellis Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.84 per share, an increase next quarter of $0.53 per share, an increase this year of $3.55 per share, and an increase next year of $2.11 per share.
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.